Predictive parameters in hypofractionated whole-breast 3D conformal radiotherapy according to the Ontario Canadian trial

References

• KoulisTAPhanTOlivottoIAHypofractionated whole breast radiotherapy: current perspectivesBreast Cancer2015736337026604820
   PubMedGoogle Scholar
• VersmessenHVinh-HungVVan ParijsHHealth-related quality of life in survivors of stage I–II breast cancer: randomized trial of post-operative conventional radiotherapy and hypofractionated tomotherapyBMC Cancer20121249523098579
   PubMedGoogle Scholar
• ZhouZRMeiXChenXXSystematic review and meta-analysis comparing hypofractionated with conventional fraction radiotherapy in treatment of early breast cancerSurg Oncol2015243200211
   Google Scholar
• BudachWBolkeEMatuschekCHypofractionated radiotherapy as adjuvant treatment in early breast cancer. A review and meta-analysis of randomized controlled trialsBreast Care20151024024526600759
   PubMed Web of Science ®Google Scholar
• WhelanTMacKenzieRJulianJRandomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancerJ Natl Cancer Inst2002941143115012165639
   PubMedGoogle Scholar
• WhelanTJPignolJPLevineMNLong-term results of hypofractionated radiation therapy for breast cancerN Engl J Med201036251352020147717
   PubMed Web of Science ®Google Scholar
• WilliamsMVDenekempJFowlerJFA review of alpha/beta ratios for experimental tumors: implications for clinical studies of altered fractionationInt J Radiat Oncol Biol Phys19851187963881377
   PubMed Web of Science ®Google Scholar
• YarnoldJBentzenSMColesCHavilandJHypofractionated whole-breast radiotherapy for women with early breast cancer: myths and realitiesInt J Radiat Oncol Biol Phys2011791920950960
   PubMed Web of Science ®Google Scholar
• SmithBDBentzenSMCorreaCRFractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based guidelineInt J Radiat Oncol Biol Phys2011811596820638191
   PubMed Web of Science ®Google Scholar
• SilvanoGLazzariGMarsellaARPostoperative Hypofractionated Whole Breast Radiotherapy in patients with early stage breast cancer: interim cosmetic and toxicity evaluationInt J Radiat Oncol Biol Phys2008721 SupplS193
   PubMedGoogle Scholar
• AaronsonNKBartelinkHvan DongenJAvan DamFSEvaluation of breast conserving therapy: clinical, methodological and psycosocial perspectivesEur J Surg Oncol1988141331403360154
   PubMedGoogle Scholar
• CoxJDStetzJPajaKTFToxicity Criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)Int J Radiat Oncol Biol Phys199531134113467713792
   PubMed Web of Science ®Google Scholar
• TaylorMEPerezCAHalversonKJFactors influencing cosmetic results after conservation therapy for breast cancerInt J Radiat Oncol Biol Phys19953147537647860386
   PubMed Web of Science ®Google Scholar
• KacprowskaAJassemJHypofractionated radiotherapy for early breast cancer: review of phase III studiesRep Pract Oncol Radiother201217667024377002
   PubMedGoogle Scholar
• YarnoldJAshtonABlissJFractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomized trialRadiother Oncol20057591715878095
   PubMed Web of Science ®Google Scholar
• HavilandJSOwenJRDewarJASTART Trialists’ GroupThe UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trialsLancet Oncol2013141086109424055415
   PubMed Web of Science ®Google Scholar
• OwenJRAshtonABlissJMEffects of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomized trialLancet Oncol2006746747116750496
   PubMed Web of Science ®Google Scholar
• LymanJTComplication probability as assessed from dose-volume histogramsRadiat Res Suppl19858S13S193867079
   PubMedGoogle Scholar
• BentzenSMYarnoldJRReports of unexpected late side-effects of accelerated partial breast irradiation – radiobiological considerationsInt J Radiat Oncol Biol Phys201077496997320610037
   PubMedGoogle Scholar
• DaleRGThe application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapyBr J Radiol1985585155284063711
   PubMed Web of Science ®Google Scholar
• FowlerJFThe linear-quadratic formula and progress in fractionated radiotherapyBr J Radiol1989626796942670032
   PubMed Web of Science ®Google Scholar
• JonesBDaleRGDeehanCHopkinsKIMorganDAThe role of biologically effective dose (BED) in clinical oncologyClin Oncol (R Coll Radiol)200113718111373882
   PubMed Web of Science ®Google Scholar
• CiammellaPPodgorniiAGaleandroMToxicity and cosmetic outcome of hypofractionated whole-breast radiotherapy: predictive clinical and dosimetric factorsRadiat Oncol201499724762173
   PubMed Web of Science ®Google Scholar
• PlataniotisGADaleRGBiologically effective dose-response relationship for breast cancer treated by conservative surgery and postoperative radiotherapyInt J Radiat Oncol Biol Phys20097551251719625139
   PubMedGoogle Scholar
• CorbinKSDornPLJainSKAl-HallaqHAHasanYChmuraSJHypofractionated radiotherapy does not increase acute toxicity in large-breasted women: results from a prospectively collected seriesAm J Clin Oncol201437432232623357972
   PubMedGoogle Scholar
• OffersenBVNielsenHMJacobsenEHHypo-vs normofractionated radiation of early breast cancer in the randomized DBCG HYPO trialRadiother Oncol2016119Suppl 1S64S65
   Google Scholar
• TortorelliGDi MurroLBarbarinoRStandard or hypofractionated radiotherapy in the postoperative treatment of breast cancer: a retrospective analysis of acute skin toxicity and dose inhomogeneitiesBMC Cancer20131323023651532
   PubMed Web of Science ®Google Scholar
• ChenMFChenWCLaiCHHungCHLiuKCChengYHPredictive factors of radiation-induced skin toxicity in breast cancer patientsBMC Cancer20101050820860847
   PubMed Web of Science ®Google Scholar
• GoldsmithCHavilandJTsangYSydenhamMYarnoldJFAST Trialists’ GroupLarge breast size as a risk factor for late adverse effects of breast radiotherapy: is residual dose inhomogeneity, despite 3D treatment planning and delivery, the main explanation?Radiother Oncol2011100223624021296441
   PubMed Web of Science ®Google Scholar
• DeantonioLGambaroGBeldìDHypofractionated radiotherapy after conservative surgery for breast cancer: analysis of acute and late toxicityRadiat Oncol2010511221092288
   PubMedGoogle Scholar
• TsangYHavilandJVenablesKYarnoldJFAST Trial Management GroupThe impact of dose heterogeneity on late normal tissue complication risk after hypofractionated whole breast radiotherapyRadiother Oncol2012104214314722809586
   PubMedGoogle Scholar
• HannanRThompsonRFChenYHypofractionated whole-breast radiation therapy: does breast size matter?Int J Radiat Oncol Biol Phys201284489490122543209
   PubMed Web of Science ®Google Scholar
• JohansenJOvergaardJOvergaardMEffect of adjuvant systemic treatment on cosmetic outcome and late normal-tissue reactions after breast conservationActa Oncol20074652553317497320
   PubMed Web of Science ®Google Scholar
• RechtAIntegration of systemic therapy and radiation therapy for patients with early-stage breast cancer treated with conservative surgeryClin Breast Cancer2003410411312864938
   PubMedGoogle Scholar
• HijalTAl HamadAANiaziTHypofractionated radiotherapy and adjuvant chemotherapy do not increase radiation-induced dermatitis in breast cancer patientsCurr Oncol2010175222720975875
   PubMedGoogle Scholar
• CurranDvan DongenJPAaronsonNKQuality of life of early-stage breast cancer patients treated with radical mastectomy or breast-conserving procedures: results of EORTC Trial 10801Eur J Cancer1998343073149640214
   PubMed Web of Science ®Google Scholar